Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases

M Passi, S Shahid, S Chockalingam… - International journal …, 2020 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is the most prevalent obstructive lung
disease worldwide characterized by decline in lung function. It is associated with airway …

Nanocarrier-based approaches to combat chronic obstructive pulmonary disease

T Virmani, G Kumar, R Virmani, A Sharma… - Nanomedicine, 2022 - Taylor & Francis
Abnormalities in airway mucus lead to chronic disorders in the pulmonary system such as
asthma, fibrosis and chronic obstructive pulmonary disease (COPD). Among these, COPD is …

Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases

MS Hussain, P Sharma, DS Dhanjal, N Khurana… - Chemico-biological …, 2021 - Elsevier
Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …

The application of nanoparticles as advanced drug delivery systems in Attenuating COPD

V Jessamine, S Mehndiratta, G De Rubis, KR Paudel… - Heliyon, 2024 - cell.com
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a dilapidating condition which is
characterized by inflammation, an excess in free radical generation and airway obstruction …

Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease

KR Paudel, M Mehta, SD Shukla, N Panth… - …, 2022 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a chronic airway disease. It is
characterized by severe inflammation mediated by inflammatory cells such as macrophages …

Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential

N Vij - Expert opinion on drug delivery, 2011 - Taylor & Francis
The major challenges in the delivery and therapeutic efficacy of nano-delivery systems in
chronic obstructive airway conditions are airway defense, severe inflammation and mucous …

Future therapeutic treatment of COPD: struggle between oxidants and cytokines

WI de Boer, H Yao, I Rahman - International journal of chronic …, 2007 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a global health problem. Being a
progressive disease characterized by inflammation and predominantly caused by tobacco …

[HTML][HTML] Current views in chronic obstructive pulmonary disease pathogenesis and management

AJ Alfahad, MM Alzaydi, AM Aldossary… - Saudi Pharmaceutical …, 2021 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a progressive lung dysfunction caused
mainly by inhaling toxic particles and cigarette smoking (CS). The continuous exposure to …

Recent advances in nanoparticle applications in respiratory disorders: a review

ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review

Y Xu, H Liu, L Song - Journal of nanobiotechnology, 2020 - Springer
Oxidative stress is significantly involved in the pathogenesis and progression of chronic
obstructive pulmonary disease (COPD). Combining antioxidant drugs or nutrients results in …